Clinical Trials Browser

Biliary Tract Neoplasms

Piebaldism, Gastrointestinal Stromal Tumors

Advanced or Metastatic Solid Tumors

Advanced or Metastatic Solid Tumors

Colorectal Neoplasms

Biliary Tract Neoplasms

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Hepatocellular

Endometrial Neoplasms

Nasopharyngeal Carcinoma

Advanced Refractory Solid Tumors

Colorectal Neoplasms

Advanced Renal Cell Carcinoma (aRCC)

Osteosarcoma

Gastrointestinal Stromal Tumors

Biliary Tract Neoplasms

Biliary Tract Neoplasms

Colorectal Neoplasms

Stomach Neoplasms

Small Cell Lung Carcinoma

Prostatic Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Non-Small-Cell Lung

Carcinoma, Hepatocellular

Sarcoma, Dermatofibrosarcoma, Histiocytoma, Malignant Fibrous

Colonic Neoplasms

Colorectal Neoplasms

Gastrointestinal Neoplasms

Pancreatic Neoplasms

Neoplasm Metastasis

Colorectal Neoplasms

Nasopharyngeal Carcinoma

Diabetes Mellitus, Insulin-Dependent, 12, Chondrosarcoma, Sarcoma

Colonic Neoplasms

Rectal Neoplasms

Lung Neoplasms

Rectal Neoplasms

Rectal Neoplasms

Esophageal Neoplasms

Uterine Cervical Neoplasms

Esophageal Squamous Cell Carcinoma

Colorectal Neoplasms

Carcinoma, Non-Small-Cell Lung

Carcinoma, Ovarian Epithelial

Biliary Tract Neoplasms

Carcinoma, Non-Small-Cell Lung

Clinical Trials

GENE

A Single-arm, Open-label, Single-center Prospective Study of Fruquintinib Combined With Envafolimab in the Treatment of Advanced or Unresectable Locally Advanced Bone and Soft Tissue Sarcoma

Neoadjuvant Treatment For Locally Advanced Thymic Cancer

Comparing Regorafenib Combined With Envafolimab to Physician's Choice in Patients With Metastatic Gastrointestinal Stromal Tumors Harboring KIT Exon 17 Mutations Refractory to Standard Treatment

This is an Open Label, Two-part, Multicenter, Phase I Trial to Investigate the Safety, Tolerability, and PK of KGX101 Monotherapy and Combination Therapy With Envafolimab in Patients With Advanced or Metastatic Solid Tumors.

A Phase I Study to Investigate the Safety and Tolerability of KGX101 Monotherapy and Combination Therapy With Envafolimab in Advanced or Metastatic Solid Tumor Patients

KN035 for dMMR/MSI-H Advanced Solid Tumors

ENVAFOLIMAB Single-agent Treatment in Patients With Advanced Solid Tumors

Multicenter Phase 2 Study of Envafolimab in Biliary Tract Cancers

Phase Ib/II Trial of Envafolimab Plus Lenvatinib for Subjects With Solid Tumors

Study of Envafolimab Alone or With Lenvatinib in Patients With Advanced Endometrial Cancer

Envafolimab Combined With Chemoradiotherapy and Recombinant Human Endostatin for LA-NPC.

Cetuximab β Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced Refractory Solid Tumors

CEIL

Envafolimab Combined With Axitinib as First-Line Treatment for Patients With Advanced Renal Cell Carcinoma

Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients

A Study of Regorafenib Combined With Envafolimab for Metastatic Gastrointestinal Stromal Tumors With Kit Gene Exon 17 Mutation That Failed Standard Treatment

Envafolimab With Chemotherapy and Simvastatin in Advanced Biliary Tract Cancer

KN035-BTC

A Clinical Study to Evaluate the Efficacy and Safety of Envafolimab Combined With Cetuxima-βand mFOLFOX6 in Patients With MSS, RAS/BRAF Wild-Type Metastatic Colorectal Cancer (mCRC)

Clinical Study of Envafolimab Combined With Fruquintinib and Chemotherapy for Neoadjuvant Treatment of Gastric Cancer

Efficacy and Safety of First-line Treatment for Extensive-stage Small Cell Lung Cancer Using a Combination Therapy of Trilaciclib, Envafolimab, Etoposide, and Carboplatin

SPRING

RC48 Monotherapy or Combination With Envafolimab for CDK12 Alterations mCRPC With Standard Treatment Failure

Local Injection and Systemic Therapy in the Treatment of NSCLC.

Trial of Chidamide in Combination With Envafolimab in Patients With PD-1 Inhibitor Resistant Advanced NSCLC.

Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With Donafenib in Combination With Envafolimab

ENVASARC

Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer

ICE Study: Combination of Irinotecan Plus Cetuximab and Envafolimab as a Rechallenge Regimen in mCRC

Endostar Combined With SBRT and Envafolimab in the Treatment of Advanced Gastrointestinal Tumors

Phase II Study of Concurrent Radiotherapy With Envafolimab and Capecitabine in LAPC

Envafolimab Combined With Chemotherapy in Metastatic or Recurrent Gastric Adenocarcinoma

A Study of Local Envafolimab Injection Combined With Chemotherapy in Non-small Cell Lung Cancer

Envafolimab Combined With Trifluridine/Tipiracil and Bevacizumab in the Treatment of Refractory mCRC.

Gemcitabine Combined With Endostar and Envafolimab in Elderly Patients With Locally Advanced Nasopharyngeal Carcinoma

YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma

ICONIC

TRACE-LE

Envafolimab Combined With Endostar in the First-line Treatment of Advanced NSCLC

RECMULRA-TNT

Preoperative Short-course Radiation Followed by Envafolimab Plus CAPEOX for MSS Locally Advanced Rectal Adenocarcinoma

Envafolimab Combined With Abraxane and Cisplatinas as Neoadjuvant Treatment for Resectable Esophageal Cancer

Study of Chemoradiotherapy With Envafolimab For The Treatment of Locally Advanced Cervical Cancer

Envafolimab Combined With Chemotherapy in Neoadjuvant Therapy for Resectable Esophageal Squamous Cell Carcinoma

Envafolimab Combined With Endostatin in Recurrent or Metastatic MSS-type Colorectal Cancer

Effect and Safety of Envafolimab Combined With Endostar/S-1 in Second-line of Advanced Non-small Cell Lung Cancer

Envafolimab, Lenvatinib Combined With VP-16 in Platinum-resistant Recurrent Epithelial Ovarian Cancer

RC48-ADC Combinatioed Envolizumab in Locally Advanced or Metastatic Biliary Tract Cancer With Positive HER-2

A Study of Envafolimab in Subjects With Stage III Non-Small Cell Lung Cancer